Spectrum Health; Frederik Meijer Heart &Vascular Institute
Grand Rapids, Michigan, 49503, United States
NCT Number: NCT01694368
To characterize atherosclerotic coronary artery plaques using advanced intra-coronary imaging with a combined near-infrared spectroscopy and intravascular ultrasound catheter before and after percutaneous intervention
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Grand Rapids, Michigan, 49503, United States
This study is being performed to characterize the composition and morphologic characteristics of atherosclerotic coronary artery plaques with intra-coronary near-infrared spectroscopy and intravascular ultrasound in patients undergoing percutaneous coronary intervention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 5 year
Corewell Health West
Other
Multimodality Advanced Intracoronary Imaging With Near-infrared Spectroscopy and Intravascular Ultrasound to Characterize Coronary Artery Plaques Before and After Percutaneous Intervention
Acronym: NIRS-IVUS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03253692
Arterial Occlusive Diseases, Arteriosclerosis
Lexington, Kentucky, United States
View Trial DetailsNCT07763769
Angina Pectoris, Angina, Stable
Washington D.C., District of Columbia, United States
View Trial DetailsNCT05336435
Acute Coronary Syndrome, Angina Pectoris
Aabenraa, Denmark
View Trial DetailsNCT07480629
Antiplatelet Therapy of Coronary Artery Bypass, Arterial Occlusive Diseases
Shanghai, China
View Trial Details